HIF1A and COVID-19: Based on this, HIF-1α activated by SARS-CoV-2 could elevate the expression of CD147 and this hypothesis can encourage researchers to consider it in future studies, opening a new window to find a new therapeutic approach for cancer patients with COVID-19.